These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8544842)

  • 21. Müllerian-inhibiting substance function during mammalian sexual development.
    Behringer RR; Finegold MJ; Cate RL
    Cell; 1994 Nov; 79(3):415-25. PubMed ID: 7954809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.
    Hirobe S; He WW; Lee MM; Donahoe PK
    Endocrinology; 1992 Aug; 131(2):854-62. PubMed ID: 1639028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
    Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
    Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
    Kananen K; Rilianawati ; Paukku T; Markkula M; Rainio EM; Huhtaniemi I
    Endocrinology; 1997 Aug; 138(8):3521-31. PubMed ID: 9231807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice.
    Wu X; Arumugam R; Baker SP; Lee MM
    Endocrinology; 2005 Feb; 146(2):589-95. PubMed ID: 15514087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gubernacular development in Müllerian inhibiting substance receptor-deficient mice.
    Bartlett JE; Lee SM; Mishina Y; Behringer RR; Yang N; Wolf J; Temelcos C; Hutson JM
    BJU Int; 2002 Jan; 89(1):113-8. PubMed ID: 11849175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
    Sriraman V; Niu E; Matias JR; Donahoe PK; MacLaughlin DT; Hardy MP; Lee MM
    J Androl; 2001; 22(5):750-8. PubMed ID: 11545286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos.
    Meyers-Wallen VN; MacLaughlin D; Palmer V; Donahoe PK
    Mol Reprod Dev; 1994 Sep; 39(1):1-7. PubMed ID: 7999353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors.
    Petraglia F; Luisi S; Pautier P; Sabourin JC; Rey R; Lhomme C; Bidart JM
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1029-32. PubMed ID: 9506769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
    Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
    Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.
    Hudson PL; Dougas I; Donahoe PK; Cate RL; Epstein J; Pepinsky RB; MacLaughlin DT
    J Clin Endocrinol Metab; 1990 Jan; 70(1):16-22. PubMed ID: 2294129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mullerian inhibiting substance: a gonadal hormone with multiple functions.
    Lee MM; Donahoe PK
    Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sertoli cell-specific rescue of fertility, but not testicular pathology, in Dax1 (Ahch)-deficient male mice.
    Jeffs B; Ito M; Yu RN; Martinson FA; Wang ZJ; Doglio LT; Jameson JL
    Endocrinology; 2001 Jun; 142(6):2481-8. PubMed ID: 11356697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Müllerian inhibiting substance in reproduction and cancer.
    Donahoe PK
    Mol Reprod Dev; 1992 Jun; 32(2):168-72. PubMed ID: 1637555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
    Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
    Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
    Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC; Matzuk MM
    Mol Endocrinol; 1999 Jun; 13(6):851-65. PubMed ID: 10379885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibin--a non-steroidal regulator of pituitary follicle stimulating hormone.
    McLachlan RI; Robertson DM; de Kretser D; Burger HG
    Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):89-112. PubMed ID: 3109368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibins, activins and anti-Müllerian hormone: structure, signalling pathways, roles and predictive value in reproductive medicine].
    Deffieux X; Antoine JM
    Gynecol Obstet Fertil; 2003 Nov; 31(11):900-11. PubMed ID: 14623553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.
    Parry RL; Chin TW; Epstein J; Hudson PL; Powell DM; Donahoe PK
    Cancer Res; 1992 Mar; 52(5):1182-6. PubMed ID: 1531323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.